Fang Xiang
Directeur/Bestuurslid bij Hrain Biotechnology Co., Ltd.
Actieve functies van Fang Xiang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 18-06-2021 | - |
Corporate Officer/Principal | 18-06-2021 | - |
Loopbaan van Fang Xiang
Opleiding van Fang Xiang
Wuhan University | Graduate Degree |
Statistieken
Internationaal
China | 3 |
Operationeel
Graduate Degree | 1 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |
- Beurs
- Insiders
- Fang Xiang
- Ervaring